Search Clinical Trials
598,375 trials
ID
Status
Phase
Title
Sponsor
NCT07765914
Zuberitamab in the First Episode of Paediatric Nephrotic SyndromeChildren's Hospital of Fudan UniversityNot Yet RecruitingPhase 3
NCT07765914Not Yet Recruiting
Phase 3
Zuberitamab in the First Episode of Paediatric Nephrotic SyndromeChildren's Hospital of Fu...
NCT07766434
A Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided Coronary REvascularization and QuAlity evaLuationChina National Center for Cardiovascular DiseasesNot Yet Recruiting
NCT07766434Not Yet Recruiting
—
A Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided...China National Center for...
NCT07766265
NEST: A Group Intervention for Parents With Complex PTSDSt.Gallen University of Applied SciencesNot Yet RecruitingNot Applicable
NCT07766265Not Yet Recruiting
Not Applicable
NEST: A Group Intervention for Parents With Complex PTSDSt.Gallen University of A...
NCT07765784
Placental Weight in Infants of Gestational Diabetic MothersKanuni Sultan Suleyman Training and Research HospitalCompleted
NCT07765784Completed
—
Placental Weight in Infants of Gestational Diabetic MothersKanuni Sultan Suleyman Tr...
NCT07764523
Home-based Whole Course Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile HealthDongying People's HospitalNot Yet RecruitingNot Applicable
NCT07764523Not Yet Recruiting
Not Applicable
Home-based Whole Course Multimodal Prehabilitation Based on 5G + Artificial Inte...Dongying People's Hospita...
NCT07765316
Targeting Pathogenic Myelopoiesis in Pancreatic CancerIRCCS San RaffaeleNot Yet Recruiting
NCT07765316Not Yet Recruiting
—
Targeting Pathogenic Myelopoiesis in Pancreatic CancerIRCCS San Raffaele
NCT07766616
Acceptance and Commitment Therapy Plus Physiotherapy for Chronic Low Back PainAl-Azhar UniversityNot Yet RecruitingNot Applicable
NCT07766616Not Yet Recruiting
Not Applicable
Acceptance and Commitment Therapy Plus Physiotherapy for Chronic Low Back PainAl-Azhar University
NCT07765745
Effect of Thymoquinone 0.2% Gel on Bone Density, Bone Width, and Socket Preservation After Tooth ExtractionKafrelsheikh UniversityRecruitingNot Applicable
NCT07765745Recruiting
Not Applicable
Effect of Thymoquinone 0.2% Gel on Bone Density, Bone Width, and Socket Preserva...Kafrelsheikh University
NCT07766252
CCHW-delivered CFH-based Cancer Prevention Program Among Chinese AmericansTexas A&M UniversityCompletedNot Applicable
NCT07766252Completed
Not Applicable
CCHW-delivered CFH-based Cancer Prevention Program Among Chinese AmericansTexas A&M University
NCT07766486
Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormone-sensitive Prostate Cancer in Patients on Androgen Deprivation TherapyFondazione del Piemonte per l'OncologiaActive Not RecruitingNot Applicable
NCT07766486Active Not Recruiting
Not Applicable
Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormo...Fondazione del Piemonte p...
NCT07766551
Construction and Validation of a Coronary Artery Disease-Specific Large Language Model and Its Evaluation Framework (CorAI)China National Center for Cardiovascular DiseasesNot Yet Recruiting
NCT07766551Not Yet Recruiting
—
Construction and Validation of a Coronary Artery Disease-Specific Large Language...China National Center for...
NCT07766499
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy and Safety of THB335 in Adult Participants With Chronic Spontaneous Urticaria (CSU)Calixis Inc.Not Yet RecruitingPhase 2
NCT07766499Not Yet Recruiting
Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multice...Calixis Inc.
NCT07764705
A Mass Balance Study of [14C]HS-10504Jiangsu Hansoh Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 1
NCT07764705Not Yet Recruiting
Phase 1
A Mass Balance Study of [14C]HS-10504Jiangsu Hansoh Pharmaceut...
NCT07764978
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCTAstraZenecaRecruitingPhase 3
NCT07764978Recruiting
Phase 3
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCTAstraZeneca
NCT07765576
Ex Vivo Thermal Damage Assessment During Electrocautery Cutting of Explanted Biopolymer-Infiltrated TissueResearch IncNot Yet Recruiting
NCT07765576Not Yet Recruiting
—
Ex Vivo Thermal Damage Assessment During Electrocautery Cutting of Explanted Bio...Research Inc
NCT07764796
Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in KenyaEmory UniversityRecruitingNot Applicable
NCT07764796Recruiting
Not Applicable
Mobile Health Patient Navigation for the Improvement of Screening and the Early...Emory University
NCT07765680
Perioperative Yoga Therapy and Endometriosis SurgeryUniversity Hospital, LilleNot Yet RecruitingNot Applicable
NCT07765680Not Yet Recruiting
Not Applicable
Perioperative Yoga Therapy and Endometriosis SurgeryUniversity Hospital, Lill...
NCT07765628
A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Participant With Moderate-to-Severe Plaque PsoriasisJiangsu Hansoh Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 2
NCT07765628Not Yet Recruiting
Phase 2
A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Participant W...Jiangsu Hansoh Pharmaceut...
NCT07766629
Recovery Trajectories After Propofol-Based Intravenous Anesthesia in Toddlers and Older ChildrenAssiut UniversityNot Yet Recruiting
NCT07766629Not Yet Recruiting
—
Recovery Trajectories After Propofol-Based Intravenous Anesthesia in Toddlers an...Assiut University
NCT07765160
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese ParticipantsInnovent Biologics (Suzhou) Co. Ltd.Not Yet RecruitingPhase 1
NCT07765160Not Yet Recruiting
Phase 1
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Parti...Innovent Biologics (Suzho...
Result Breakdown
Not yet recruiting14 (70%)
Recruiting3 (15%)
Completed2 (10%)
Active, not recruiting1 (5%)
not_applicable8 (40%)
Not Specified6 (30%)
Phase 32 (10%)
Phase 22 (10%)
Phase 12 (10%)